*Palliative Therapy of Bone Metastases DOI: http://dx.doi.org/10.5772/intechopen.107895*

Most metastases are osteolytic. Patients with primary prostate cancer develop osteoblastic metastases. Also, most of the metastases that are the primary source of breast, thyroid, and kidney cancers are osteolytic. Although patients with breast cancer are more likely to develop osteolytic metastases, between 15% and 20% of patients develop osteoblastic metastases or a combination of both.
